Macrogenics (MGNX) Misses Q2 EPS by 11c, Misses on Revenue

Macrogenics (NASDAQ: MGNX) reported Q2 EPS of ($0.57), $0.11 worse than the analyst estimate of ($0.46). Revenue for the quarter came in at $22.2 million versus the consensus estimate of $28.06 million.

For earnings history and earnings-related data on Macrogenics (MGNX) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Correction: Kepler Cheuvreux Upgrades Siemens AG (SIE:GR) (SIEGY) to Hold
• Raymond James Upgrades Aecon Group (ARE:CN) (AEGXF) to Outperform